GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pet Pharm Biotech Co Ltd (ROCO:7762) » Definitions » Purchase Of Investment

Pet Pharm Biotech Co (ROCO:7762) Purchase Of Investment : NT$-65.0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Pet Pharm Biotech Co Purchase Of Investment?

Pet Pharm Biotech Co's purchase of investment for the six months ended in Dec. 2024 was NT$-15.0 Mil. It means Pet Pharm Biotech Co spent NT$15.0 Mil on purchasing investments. Pet Pharm Biotech Co's purchase of investment for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-65.0 Mil.

Compared with last quarter (NT$-50.0 Mil in Jun. 2024 ), Pet Pharm Biotech Co spent less money on purchasing investments in Dec. 2024 (NT$-15.0 Mil).


Pet Pharm Biotech Co Purchase Of Investment Historical Data

The historical data trend for Pet Pharm Biotech Co's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pet Pharm Biotech Co Purchase Of Investment Chart

Pet Pharm Biotech Co Annual Data
Trend Dec22 Dec23 Dec24
Purchase Of Investment
-50.00 -91.00 -65.00

Pet Pharm Biotech Co Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24
Purchase Of Investment - -100.00 9.00 -50.00 -15.00

Pet Pharm Biotech Co Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-65.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pet Pharm Biotech Co Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Pet Pharm Biotech Co's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Pet Pharm Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
143, Hougang 1st Road, 1-2F., No. 141, Xinzhuang District, New Taipei City, TWN, 242051
Pet Pharm Biotech Co Ltd is a Pharmaceutical company. The company is engaged in manufacturing medicinal products and medicine drugs. The products offered by the company include FDG Fluodeoxyglucose Injection (18F-FDG), Naolixi Injection (18F-FBB), Sodium fluoride injection (18F-NaF), and others.

Pet Pharm Biotech Co Headlines

No Headlines